Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Drug-Delivery Technology Market Report 2026

globenewswire.com
MRK Merck & Co. is listed as a leading market player in the drug-delivery technology market, contributing to market dynamism through innovation and strategic collaborations. The article does not provide specific sentiment towards the company's performance. ABBV AbbVie Inc. is identified as a leading market player in the drug-delivery technology sector. The article mentions its contribution to market dynamism through innovation and strategic collaborations but does not offer specific performance indicators or sentiment. SNY Sanofi S.A. is mentioned as a leading company in the drug-delivery technology market, contributing to its dynamism through innovation and collaborations. No specific performance data or sentiment is provided. AZN AstraZeneca Plc is named as a leading player in the drug-delivery technology market. The article notes its contribution to market dynamism via innovation and strategic collaborations, but lacks specific sentiment. NVS Novartis AG is listed as a leading market player in the drug-delivery technology sector. The article mentions its contribution to market dynamism through innovation and strategic collaborations, without providing specific sentiment. GSK GlaxoSmithKline Plc. is mentioned as a major company in the drug-delivery technology market. The article notes its contribution to market dynamism through innovation and strategic collaborations, but does not offer specific sentiment. TEVA Teva Pharmaceutical Industries Ltd. is listed as a major company in the drug-delivery technology market. The article notes its contribution to market dynamism through innovation and strategic collaborations, but does not offer specific sentiment. REGN Regeneron Pharmaceuticals Inc. is mentioned as a major company in the drug-delivery technology market. The article notes its contribution to market dynamism through innovation and strategic collaborations, but does not offer specific sentiment. VRTX Vertex Pharmaceuticals Incorporated is listed as a major company in the drug-delivery technology market. The article notes its contribution to market dynamism through innovation and strategic collaborations, but does not offer specific sentiment. ALKS Alkermes plc. is mentioned as a major company in the drug-delivery technology market. The article notes its contribution to market dynamism through innovation and strategic collaborations, but does not offer specific sentiment. HALO Halozyme Therapeutics Inc. is listed as a major company in the drug-delivery technology market. The article notes its contribution to market dynamism through innovation and strategic collaborations, but does not offer specific sentiment.

Drug-Delivery Technology Market Report 2026 Dublin, July 08, 2026 (GLOBE NEWSWIRE) -- The "Drug-Delivery Technology Market Report 2026" has been added to ResearchAndMarkets.com's offering.

The drug-delivery technology market has witnessed rapid growth and is set to expand further. Estimated to climb from $54.24 billion in 2025 to $60.27 billion in 2026 with an 11.1% CAGR, it shows potential to reach $91.41 billion by 2030 at an 11% CAGR. Contributing factors include innovations in medical devices, a surge in chronic diseases, and demand for better patient compliance.

The expansion in personalized medicine, biologics, biosimilars, and advanced drug-delivery technologies fuels this growth. Key trends include targeted delivery systems, sustained release formulations, and minimally invasive technologies that enhance patient care.

Chronic diseases' increasing prevalence significantly propels market expansion. Factors such as sedentary lifestyles and related health complications emphasize the need for targeted and effective drug-delivery systems, which improve treatment outcomes and patient adherence. Notably, the 2023 Australian Burden of Disease Study highlighted chronic conditions account for a substantial portion of both non-fatal and fatal health burdens.

Companies are innovating with products like prefilled injection devices to enhance dosing accuracy and patient convenience. For instance, Phillips-Medisize LLC introduced a disposable pen injector aimed at various therapies in February 2023, facilitating faster market entry and reducing costs.

In January 2025, Molex, through Phillips Medisize, strengthened its portfolio by acquiring Vectura Group Ltd., thereby amplifying its expertise in inhalation formulation and device development. This strategic move enhances offerings in respiratory and combination therapies, aligning with evolving market needs.

Leading market players include Merck & Co., AbbVie, Bayer, Sanofi, AstraZeneca, and Novartis among others, all contributing to market dynamism through innovation and strategic collaborations.

Regionally, North America led the market in 2025, while Asia-Pacific is anticipated to grow the fastest in the coming years, driven by increasing healthcare needs and technological adoption. Areas like Asia-Pacific, South East Asia, and Europe remain pivotal to the market's future trajectory.

Tariffs have influenced the market by raising costs for imported components, notably affecting injectable and implantable segments. However, this has also bolstered local manufacturing capabilities, fostering a more resilient supply chain and sustaining innovation.

The comprehensive drug-delivery technology market reports provide a nuanced understanding of market trends, opportunities, and competitive dynamics, offering a complete industry perspective essential for strategic decision-making.

This market's focus spans oral, injectable, transdermal, and implantable delivery systems, aiming to optimize therapeutic effects and patient compliance across various medical conditions and care settings. Such advanced systems underscore the market's commitment to innovative healthcare solutions.

Overall, the drug-delivery technology market is poised for robust growth due to its pivotal role in enhancing drug efficacy and improving patient outcomes in an ever-evolving healthcare landscape.

The Drug-Delivery Technology Market Global Report 2026 is an essential resource for strategists, marketers, and senior management, offering critical insights for assessing the burgeoning drug-delivery technology market. As the market experiences robust growth, this report outlines the emerging trends poised to shape it over the next decade and beyond.

Reasons to Purchase:

Description:

Where does the drug-delivery technology market find its largest and fastest growth? How does it fit within the broader economic environment, demographics, and related markets? This global report on the drug-delivery technology market addresses these questions and more, examining market characteristics, size, growth, segmentation, and regional breakdowns, alongside a comprehensive overview of the market's competitive landscape.

Report Scope:

Markets Covered:

1) By Type: Oral, Injectable, Topical, Ocular, Nasal, Pulmonary, Transmucosal, Implantable

2) By Application: Cardiovascular Diseases, Oncology, Urology, Diabetes, CNS, Ophthalmology, Infections, Other Applications

3) By End User: Hospitals, Clinics, Diagnostic Centers, Home Care Settings

Companies Mentioned: Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc., Cipla Limited, Teva Pharmaceutical Industries Ltd., among others.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Regions: Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time Series: Historical data for five years and forecast for ten years.

Data: Covers market size ratios and growth in relation to other markets, economic proportions, and per capita spending.

Delivery Format: Available in Word, PDF, or as an Interactive Report with an Excel Dashboard

Added Benefits:

Key Attributes:

Key Topics Covered:

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Drug-Delivery Technology Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Drug-Delivery Technology Market Attractiveness Scoring and Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment and Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Drug-Delivery Technology Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List of Key Raw Materials, Resources & Suppliers

3.3. List of Major Distributors and Channel Partners

3.4. List of Major End Users

4. Global Drug-Delivery Technology Market Trends and Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Industry 4.0 & Intelligent Manufacturing

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Sustainability, Climate Tech & Circular Economy

4.1.5 Artificial Intelligence & Autonomous Intelligence

4.2. Major Trends

4.2.1 Targeted Drug Delivery Systems

4.2.2 Controlled and Sustained Release Formulations

4.2.3 Patient Centric Drug Delivery Devices

4.2.4 Minimally Invasive Delivery Technologies

4.2.5 Advanced Implantable Drug Systems

5. Drug-Delivery Technology Market Analysis of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Diagnostic Centers

5.4 Home Care Settings

5.5 Pharmaceutical Companies

6. Drug-Delivery Technology Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, and Covid and Recovery on the Market

7. Global Drug-Delivery Technology Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis

7.1. Global Drug-Delivery Technology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Drug-Delivery Technology Market Size, Comparisons and Growth Rate Analysis

7.3. Global Drug-Delivery Technology Historic Market Size and Growth, 2020-2025, Value ($ Billion)

7.4. Global Drug-Delivery Technology Forecast Market Size and Growth, 2025-2030, 2035F, Value ($ Billion)

8. Global Drug-Delivery Technology Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Drug-Delivery Technology Market Segmentation

9.1. Global Drug-Delivery Technology Market, Segmentation by Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Injectable, Topical, Ocular, Nasal, Pulmonary, Transmucosal, Implantable

9.2. Global Drug-Delivery Technology Market, Segmentation by Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cardiovascular Diseases, Oncology, Urology, Diabetes, Central Nervous System (CNS), Ophthalmology, Infections, Other Applications

9.3. Global Drug-Delivery Technology Market, Segmentation by End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Diagnostic Centers, Home Care Settings, Other End Users

9.4. Global Drug-Delivery Technology Market, Sub-Segmentation of Oral, by Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Tablets, Capsules, Solutions, Suspensions, Powders, Gels

9.5. Global Drug-Delivery Technology Market, Sub-Segmentation of Injectable, by Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Conventional Injection, Self-Injection, Long-Acting Injection

9.6. Global Drug-Delivery Technology Market, Sub-Segmentation of Topical, by Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Creams, Gels, Lotions, Patches, Ointments

9.7. Global Drug-Delivery Technology Market, Sub-Segmentation of Ocular, by Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Eye Drops, Ointments, Gels, Inserts, Implants

9.8. Global Drug-Delivery Technology Market, Sub-Segmentation of Nasal, by Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Sprays, Drops, Powders, Gels

9.9. Global Drug-Delivery Technology Market, Sub-Segmentation of Pulmonary, by Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers

9.10. Global Drug-Delivery Technology Market, Sub-Segmentation of Transmucosal, by Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Buccal, Sublingual, Rectal, Vaginal

9.11. Global Drug-Delivery Technology Market, Sub-Segmentation of Implantable, by Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Biodegradable Implants, Non-Biodegradable Implants, Drug-Eluting Stents

10. Drug-Delivery Technology Market, Industry Metrics by Country

10.1. Global Drug-Delivery Technology Market, Average Selling Price by Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $

10.2. Global Drug-Delivery Technology Market, Average Spending Per Capita (Employed) by Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $

11. Drug-Delivery Technology Market Regional and Country Analysis

11.1. Global Drug-Delivery Technology Market, Split by Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11.2. Global Drug-Delivery Technology Market, Split by Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. Asia-Pacific Drug-Delivery Technology Market

12.1. Asia-Pacific Drug-Delivery Technology Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. Asia-Pacific Drug-Delivery Technology Market, Segmentation by Type, Segmentation by Application, Segmentation by End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. China Drug-Delivery Technology Market

13.1. China Drug-Delivery Technology Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

13.2. China Drug-Delivery Technology Market, Segmentation by Type, Segmentation by Application, Segmentation by End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. India Drug-Delivery Technology Market

14.1. India Drug-Delivery Technology Market, Segmentation by Type, Segmentation by Application, Segmentation by End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Japan Drug-Delivery Technology Market

15.1. Japan Drug-Delivery Technology Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

15.2. Japan Drug-Delivery Technology Market, Segmentation by Type, Segmentation by Application, Segmentation by End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Australia Drug-Delivery Technology Market

16.1. Australia Drug-Delivery Technology Market, Segmentation by Type, Segmentation by Application, Segmentation by End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Indonesia Drug-Delivery Technology Market

17.1. Indonesia Drug-Delivery Technology Market, Segmentation by Type, Segmentation by Application, Segmentation by End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. South Korea Drug-Delivery Technology Market

18.1. South Korea Drug-Delivery Technology Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. South Korea Drug-Delivery Technology Market, Segmentation by Type, Segmentation by Application, Segmentation by End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Taiwan Drug-Delivery Technology Market

19.1. Taiwan Drug-Delivery Technology Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. Taiwan Drug-Delivery Technology Market, Segmentation by Type, Segmentation by Application, Segmentation by End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. South East Asia Drug-Delivery Technology Market

20.1. South East Asia Drug-Delivery Technology Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. South East Asia Drug-Delivery Technology Market, Segmentation by Type, Segmentation by Application, Segmentation by End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Western Europe Drug-Delivery Technology Market

21.1. Western Europe Drug-Delivery Technology Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

21.2. Western Europe Drug-Delivery Technology Market, Segmentation by Type, Segmentation by Application, Segmentation by End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. UK Drug-Delivery Technology Market

22.1. UK Drug-Delivery Technology Market, Segmentation by Type, Segmentation by Application, Segmentation by End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. Germany Drug-Delivery Technology Market

23.1. Germany Drug-Delivery Technology Market, Segmentation by Type, Segmentation by Application, Segmentation by End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. France Drug-Delivery Technology Market

24.1. France Drug-Delivery Technology Market, Segmentation by Type, Segmentation by Application, Segmentation by End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Italy Drug-Delivery Technology Market

25.1. Italy Drug-Delivery Technology Market, Segmentation by Type, Segmentation by Application, Segmentation by End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Spain Drug-Delivery Technology Market

26.1. Spain Drug-Delivery Technology Market, Segmentation by Type, Segmentation by Application, Segmentation by End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Eastern Europe Drug-Delivery Technology Market

27.1. Eastern Europe Drug-Delivery Technology Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

27.2. Eastern Europe Drug-Delivery Technology Market, Segmentation by Type, Segmentation by Application, Segmentation by End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Russia Drug-Delivery Technology Market

28.1. Russia Drug-Delivery Technology Market, Segmentation by Type, Segmentation by Application, Segmentation by End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. North America Drug-Delivery Technology Market

29.1. North America Drug-Delivery Technology Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. North America Drug-Delivery Technology Market, Segmentation by Type, Segmentation by Application, Segmentation by End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. USA Drug-Delivery Technology Market

30.1. USA Drug-Delivery Technology Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. USA Drug-Delivery Technology Market, Segmentation by Type, Segmentation by Application, Segmentation by End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. Canada Drug-Delivery Technology Market

31.1. Canada Drug-Delivery Technology Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. Canada Drug-Delivery Technology Market, Segmentation by Type, Segmentation by Application, Segmentation by End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. South America Drug-Delivery Technology Market

32.1. South America Drug-Delivery Technology Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

32.2. South America Drug-Delivery Technology Market, Segmentation by Type, Segmentation by Application, Segmentation by End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Brazil Drug-Delivery Technology Market

33.1. Brazil Drug-Delivery Technology Market, Segmentation by Type, Segmentation by Application, Segmentation by End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Middle East Drug-Delivery Technology Market

34.1. Middle East Drug-Delivery Technology Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Middle East Drug-Delivery Technology Market, Segmentation by Type, Segmentation by Application, Segmentation by End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Africa Drug-Delivery Technology Market

35.1. Africa Drug-Delivery Technology Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

35.2. Africa Drug-Delivery Technology Market, Segmentation by Type, Segmentation by Application, Segmentation by End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

36. Drug-Delivery Technology Market Regulatory and Investment Landscape

37. Drug-Delivery Technology Market Competitive Landscape and Company Profiles

37.1. Drug-Delivery Technology Market Competitive Landscape and Market Share 2024

37.1.1. Top 10 Companies (Ranked by revenue/share)

37.2. Drug-Delivery Technology Market - Company Scoring Matrix

37.2.1. Market Revenues

37.2.2. Product Innovation Score

37.2.3. Brand Recognition

37.3. Drug-Delivery Technology Market Company Profiles

37.3.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

37.3.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

37.3.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

37.3.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

37.3.5. AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis

38. Drug-Delivery Technology Market Other Major and Innovative Companies

Novartis AG, GlaxoSmithKline Plc., Cipla Limited, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Chiesi Farmaceutici S.p.A., United Therapeutics Corporation, Mallinckrodt Pharmaceuticals Plc., Lupin Pharmaceuticals, Inc., Glenmark Pharmaceuticals Limited, Alkermes plc., Halozyme Therapeutics Inc., Sunovion Pharmaceuticals Inc., Circassia Pharmaceuticals Plc.

39. Global Drug-Delivery Technology Market Competitive Benchmarking and Dashboard

40. Key Mergers and Acquisitions in the Drug-Delivery Technology Market

41. Drug-Delivery Technology Market High Potential Countries, Segments and Strategies

41.1. Drug-Delivery Technology Market in 2030 - Countries Offering Most New Opportunities

41.2. Drug-Delivery Technology Market in 2030 - Segments Offering Most New Opportunities

41.3. Drug-Delivery Technology Market in 2030 - Growth Strategies

41.3.1. Market Trend Based Strategies

41.3.2. Competitor Strategies

42. Appendix

42.1. Abbreviations

42.2. Currencies

42.3. Historic and Forecast Inflation Rates

42.4. Research Inquiries

42.5. About the Analyst

42.6. Copyright and Disclaimer

Companies Featured

The companies featured in this Drug-Delivery Technology market report include:

For more information about this report visit https://www.researchandmarkets.com/r/6lz1p0

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment